Frank Mattner
24Patents
5h-index
35Co-inventors
69Inventor score
Filing activity: Apr 30, 1997 → Jul 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5928636A | Use of IL-12 and IFN.alpha. for the treatment of infectious diseases | Emerging Cross-Sectional Technologies | 65 | Expired |
| US7148191B2 | Antigenic composition | Chemistry; Metallurgy | 38 | Expired |
| US7732568B2 | Methods for preventing and treating Alzheimer's disease | Chemistry; Metallurgy | 10 | Active |
| US7378234B2 | Method for isolating hepatitis C virus peptides | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7244438B2 | Uses for polycationic compounds | Human Necessities | 7 | Expired |
| US8613931B2 | Compounds for treating beta-amyloidoses | Chemistry; Metallurgy | 5 | Active |
| US7935348B2 | Combination therapy for the treatment of Alzheimer's disease | Human Necessities | 4 | Active |
| US7528223B2 | Antigens encoded by alternative reading frames from pathogenic viruses | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8277815B2 | Pharmaceutical composition comprising an antigen | Chemistry; Metallurgy | 3 | Active |
| US8022180B2 | Method for preventing and treating Alzheimer's disease | Physics | 3 | Active |
| US7935252B2 | Methods of treating Alzheimer's Disease with an apheresis device | Human Necessities | 3 | Active |
| US8361476B2 | Vaccine composition comprising an antigen and a peptide having adjuvant properties | Emerging Cross-Sectional Technologies | 2 | Active |
| US7658928B2 | Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide | Human Necessities | 2 | Active |
| US11065273B2 | Treatment and prevention of alzheimer's disease (AD) | Human Necessities | 1 | Active |
| US8618046B2 | Treatment of atherosclerosis with cholesterol ester transport protein mimotopes | Human Necessities | 1 | Active |
| US10646565B2 | Treatment of alzheimer'S disease (AD) with an aluminum salt | Human Necessities | 1 | Active |
| US11147873B2 | Treatment of Alzheimer's Disease (AD) with an aluminum salt | Human Necessities | 1 | Active |
| US9625459B2 | Method for diagnosing alzheimer's disease (AD) | Physics | 1 | Active |
| US9029327B2 | Vaccine | Human Necessities | 0 | Active |
| US9457078B2 | Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein | Human Necessities | 0 | Active |
| US11857568B2 | Treatment and prevention of Alzheimer's disease (AD) | Human Necessities | 0 | Active |
| US10344062B2 | Method of inhibiting C5a | Chemistry; Metallurgy | 0 | Active |
| US10478454B2 | Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide | Human Necessities | 0 | Active |
| US8900564B2 | Vaccine composition comprising an antigen and a peptide having adjuvant properties | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.